Platelet‐activating factor antagonist‐based intensive antiplatelet strategy in acute ischemic stroke: A propensity score matched with network pharmacology analysis

BACKGROUND: Diterpene ginkgolides meglumine injection (DGMI) is a platelet‐activating factor receptor (PAFR) antagonist that can be used to treat acute ischemic stroke (AIS). This study evaluated the efficacy and safety of an intensive antiplatelet strategy based on PAFR antagonists and explored the...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaoyan, Li, Youjia, Chen, Xuemin, Pan, Dong, Mo, Junning, Qiu, Jiaming, Li, Yi, Chen, Yan, Huang, Yan, Shen, Qingyu, Tang, Yamei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651968/
https://www.ncbi.nlm.nih.gov/pubmed/37435773
http://dx.doi.org/10.1111/cns.14331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651968/
https://www.ncbi.nlm.nih.gov/pubmed/37435773
http://dx.doi.org/10.1111/cns.14331

Ejemplares similares